Search Results - "Ulman, Katherine"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Elemental Impurities in Pharmaceutical Excipients by Li, Gang, Schoneker, Dave, Ulman, Katherine L, Sturm, Jason J, Thackery, Lisa M, Kauffman, John F

    Published in Journal of pharmaceutical sciences (01-12-2015)
    “…Control of elemental impurities in pharmaceutical materials is currently undergoing a transition from control based on concentrations in components of drug…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Mitigating the Risk from Excipient Variability by Carlin, Brian, Collins, George, Moreton, Christian, Schoneker, David, Putnam, Jennifer, Zeleznik, Joseph, Ulman, Katherine, Bremer, Stacey

    Published in Pharmaceutical Technology (01-08-2022)
    “…Particle size is usually controlled as an average or distribution, and dilute solution viscosities are often used for routine analysis to monitor…”
    Get full text
    Trade Publication Article
  4. 4

    Comparison of Pharmaceutical Excipients and Food Ingredient Requirements by Grocholi, Luke, Zawislak, Priscilla, Moreton, R Christian, Ulman, Katherine L

    Published in Pharmaceutical Technology (01-04-2020)
    “…[...]it is also incorrect to assume that product approved for use as a pharmaceutical excipient will automatically comply with food or dietary supplement…”
    Get full text
    Trade Publication Article
  5. 5

    Third-Party Audits: Ensuring That Excipients Meet cGMP Requirements by Klug, David B, Lindblad, Ralph D, Muse, Douglas G, Ulman, Katherine L, Walsh, Phyllis, Zawislak, Priscilla S

    Published in Pharmaceutical Technology (01-09-2018)
    “…[...]party audits offer a way to reduce the cost of audits, both for the pharmaceutical manufacturer and the excipient supplier. Followup communications…”
    Get full text
    Trade Publication Article
  6. 6

    Establishing limits for dermal absorption of elemental impurities by Teasdale, Andrew, Ulman, Katherine, Domoradzki, Jean, Walsh, Phyllis

    Published in Pharmaceutical Technology (01-09-2015)
    “…The International Conference on Harmonization's (ICH's) Q3D Guideline For Elemental Impurities establishes acceptable exposure limits and defines these limits…”
    Get full text
    Magazine Article Trade Publication Article
  7. 7
  8. 8

    Elemental impurities: an industry perspective on harmonization and implementation of ICH and USP requirements by Ulman, Katherine, Schwarzwalder, Neil, Teasdale, Andrew, Schoneker, David, Zawislak, Priscilla

    Published in Pharmaceutical Technology (01-11-2012)
    “…The US Pharmacopeia's revised General Chapters on elemental impurity limits and testing procedures are set to take effect in December 2012, and are to be…”
    Get full text
    Magazine Article Trade Publication Article
  9. 9
  10. 10

    Additives and Processing Aids in Pharmaceutical Excipients by Collins, George, Ulman, Katherine, Muse, Douglas G, Tocce, Elizabeth, Zawislak, Priscilla, Zeleznik, Joseph

    Published in Pharmaceutical Technology (01-10-2019)
    “…[...]there are a large number of excipients in approved medicines that contain undeclared additives, processing aids, and/or concomitant components…”
    Get full text
    Trade Publication Article
  11. 11
  12. 12

    Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and Opportunities by Teasdale, Andrew, Chéry, Cyrille C, Cook, Graham, Glennon, John, Harris, Laurence, Lee, Carlos W, Lewen, Nancy, Nethercote, Phil, Powell, Samuel, Rockstroh, Helmut, Rutter, Laura, Smallshaw, Lance, Thompson, Sarah, Woodward, Vicki, Ulman, Katherine

    Published in Pharmaceutical Technology (01-03-2015)
    “…New guidelines relating to elemental impurities from the International Conference on Harmonization (ICH), Q3D Guideline for Elemental Impurities have presented…”
    Get full text
    Trade Publication Article
  13. 13